<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-CEO-2072</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2072</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Корригирующие эффекты оригинального комплекса биофлавоноидов при циклофосфан-индуцированных нарушениях иммунитета</article-title><trans-title-group xml:lang="en"><trans-title>Corrective effects of original bioflavonoid complex in the cyclophosphamide-induced immunity disorders</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8246-9552</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гольдина</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Goldina</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гольдина Ирина Александровна – научный сотрудник лаборатории нейроиммунологии</p><p>630099, г. Новосибирск, ул. Ядринцевская, 14</p></bio><bio xml:lang="en"><p>Goldina Irina A., Research Associate, Neuroimmunology Laboratory</p><p>630099, Novosibirsk, Yadrintsevskaya str., 14</p><p> </p></bio><email xlink:type="simple">igoldina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маркова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Markova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маркова Евгения Валерьевна – доктор медицинских наук, главный научный сотрудник, руководитель лаборатории нейроиммунологии</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Markova Engeniya V., PhD, MD (Medicine), Chief Research Associate, Neuroimmunology Laboratory</p><p>Novosibirsk</p></bio><email xlink:type="simple">evgeniya_markova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орловская</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Orlovskaya</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Орловская Ирина Анатольевна – доктор медицинских наук, профессор, главный научный сотрудник, руководитель лаборатории иммунобиологии стволовой клетки</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Orlovskaya Irina A., PhD, MD (Medicine), Professor, Chief Research Associate, Head, Laboratory of Stem Cell Immunobiology</p><p>Novosibirsk</p></bio><email xlink:type="simple">irorl@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Топоркова</surname><given-names>Л. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Toporkova</surname><given-names>L. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Топоркова Людмила Борисовна – кандидат биологических наук, старший научный сотрудник лаборатории иммунобиологии стволовой клетки</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Toporkova Ludmila B., PhD (Biology), Senior Research Associate, Laboratory of Stem Cell Immunobiology</p><p>Novosibirsk</p></bio><email xlink:type="simple">toporkova12@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козлов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozlov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Козлов Владимир Александрович – доктор медицинских наук, профессор, академик РАН, научный руководитель</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Kozlov Vladimir A., PhD, MD (Medicine), Full Member, Russian Academy of Sciences, Professor, Scientific Director</p><p>Novosibirsk</p></bio><email xlink:type="simple">vakoz40@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт фундаментальной и клинической иммунологии»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Fundamental and Clinical Immunology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>31</day><month>12</month><year>2020</year></pub-date><volume>22</volume><issue>6</issue><fpage>1111</fpage><lpage>1120</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гольдина И.А., Маркова Е.В., Орловская И.А., Топоркова Л.Б., Козлов В.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Гольдина И.А., Маркова Е.В., Орловская И.А., Топоркова Л.Б., Козлов В.А.</copyright-holder><copyright-holder xml:lang="en">Goldina I.A., Markova E.V., Orlovskaya I.A., Toporkova L.B., Kozlov V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2072">https://www.mimmun.ru/mimmun/article/view/2072</self-uri><abstract><p>С целью исследования иммуномодулирующих свойств оригинального комплекса биофлавоноидов при циклофосфан-индуцированных нарушениях иммунитета были изучены морфометрические показатели тимуса и селезенки, количество лейкоцитов периферической крови, пролиферативная активность клеток лимфоидных органов, выраженность реакции гиперчувствительности замедленного типа к Т-зависимому антигену, а также дифференцировочная активность гемопоэтической стволовой клетки костного мозга экспериментальных животных на фоне циклофосфан-индуцированной иммуносупрессии после курсового введения им комплекса биофлавоноидов. Суспензию комплекса биофлавоноидов принудительно вводили мышам-самцам (СВАхC57Bl/6) F1 12-14-недельного возраста из расчета 2 мг/мышь (80 мг/кг), per os, c помощью зонда в желудок, ежедневно в течение 14 суток. Цитостатическую иммуносупрессию воспроизводили однократным внутрибрюшинным введением животным циклофосфана. Пролиферативную активность клеток селезенки и тимуса определяли стандартным методом, при включению Н3 тимидина в 72-часовую культуру клеток. Клеточный иммунный ответ определяли по интенсивности развития реакции гиперчувствительности замедленного типа в ответ на введение эритроцитов барана. Количество гемопоэтических клеток-предшественников оценивали при культивировали клеток костного мозга в метилцеллюлозной среде. В результате проведенных экспериментов было показано, что на фоне курсового введения комплекса биофлавоноидов супрессивные эффекты циклофосфана нивелировались в отношении абсолютной и относительной массы лимфоидных органов и количества лейкоцитов периферической крови. При этом продемонстрировано снижение супрессивного влияния циклофосфана на спонтанную пролиферативную активность клеток селезенки, митоген-индуцированную пролиферацию тимоцитов и спленоцитов, интенсивность реакции гиперчувствительности замедленного типа, значения которых соответствовали таковым у интактных животных. У животных после курсового введения комплекса биофлавоноидов выявлено также увеличение количества ранних гемопоэтических клеток-предшественников. Установленное в настоящем исследовании нивелирование супрессивного влияния циклофосфана на клеточный иммунный ответ, пролиферативную активность клеток иммунной системы, а также стимуляция функциональной активности гемопоэтической стволовой клетки, свидетельствуют о существенном иммуно-гемопоэзмодулирующем потенциале оригинального комплекса биофлавоноидов и является экспериментальным доказательством перспективности его использования в качестве адъювантного средства при лечении больных онкологического профиля.</p></abstract><trans-abstract xml:lang="en"><p>Our aim was to evaluate immunomodulatory properties of an original bioflavonoid complex in experimental immune disturbances induced by cyclophosphamide (Cy). We have studied morphometric indexes of thymus and spleen, as well as blood leukocyte counts, cell proliferative activity in lymphoid organs, delayed hypersensitivity responses to T cell-dependent antigen, along with differentiation activity of bone marrow stem cells in experimental animals during Cy-induced immune suppression after a course of bioflavonoid treatment. Suspension of the bioflafonoid complex was introduced to the male mice (СВАхC57Bl/6)F1 aged 12- 14 weeks at a daily dose of 2 mg/animal (80 mg/kg), per os, using gastric catheter, over 14 days. Cytostatic immunosuppression was produced by a single intraperitoneal Cy injection. Proliferative activity of spleen and thymic cells was determined by standard method with Н3 -thymidine incorporation in the 72-h cell culture. Cellular immune response was assayed by the degree of delayed-type hypersensitivity development in response to sheep erythrocytes. The number of hematopoietic progenitors was evaluated by culturing bone marrow cells in methylcellulose-based medium. The experiments have shown mitigation of immunosuppressive effects induced by Cy, in the course of bioflavonoid complex treatment, with respect to absolute and relative mass of lymphoid organs and leukocyte numbers in peripheral blood. Moreover, we have demonstrated decreased effects of Cy treatment upon the spontaneous activity of spleen cells, mitogen-induced thymocyte and splenocyte proliferation, intensivity of delayed-type hypersensitivity response that reached the values of intact animals. Following the course of bioflavonoids, we have revealed an increase in early hematopoietic progenitors. Alleviation of Cy-induced suppressive effects upon cellular immune response, proliferation rates of immune cells, as well as stimulation of hematopoietic stem cell functions suggest a sufficient capacity of the original bioflavonoid complex for modulation of immunity and hematopoiesis, thus presenting experimental proofs for its potential usage as an adjuvant treatment of the patients with malignant diseases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>биофлавоноиды</kwd><kwd>стволовые кроветворные клетки</kwd><kwd>иммунные клетки</kwd><kwd>пролиферативная активность</kwd><kwd>иммунный ответ</kwd><kwd>циклофосфан</kwd><kwd>иммуносупрессия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>bioflavonoids</kwd><kwd>hemopoietic stem cells</kwd><kwd>immune cells</kwd><kwd>proliferative activity</kwd><kwd>immune response</kwd><kwd>cyclophosphamide</kwd><kwd>immuno suppression</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена по теме из Плана НИР НИИФКИ, № гос. регистрации 01201356998</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Гайдуль К.В., Гольдина И.А., Сафронова И.В. Исследование морфометрических параметров органов иммунной системы под действием нутрицевтика эпигеном-направленного действия на фоне экспериментальной гемодепрессии // Здоровье и образование в XXI веке, 2018. Т. 20, № 10. С. 10-13.</mixed-citation><mixed-citation xml:lang="en">Gaidul K.V., Goldina I.A., Safronova I.V. Investigation of the morphometric parameters of immune system organs at experimental hemosupression under the influence of nutraceutical with epigenome-directed action. Zdorovye i obrazovanie v XXI veke = Health and Education Millenium, 2018, Vol. 20, no. 10, pp. 10-13. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Гольдина И.А., Гайдуль К.В. Биологическая активность и терапевтические свойства Curcuma Longa L. (обзор литературы) // Вестник НГУ, 2015. № 1. С. 141-149.</mixed-citation><mixed-citation xml:lang="en">Goldina I.A., Gaidul K.V. Biologica activity and therapeutic properties of Curcuma Longa L. (Review). Vestnik NGU = Bulletin of NSU, 2015, no. 1, pp. 141-149. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Гольдина И.А., Маркова Е.В., Гольдин Б.Г., Княжева М.А., Гайдуль К.В. Протекторные свойства экстракта куркумы при этанол-индуцированных нарушениях поведения // Саратовский научно-медицинский журнал, 2017. Т. 13, № 1. С. 131-135.</mixed-citation><mixed-citation xml:lang="en">Goldina I.A., Markova E.V., Goldin B.G., Knyazheva M.A., Gaidul K.V. The turmeric protective properties at ethanol-induced behavioral disorders. Saratovskiy nauchno-meditsinskiy zhurnal = Saratov Medical Journal, 2017, Vol. 13, no. 1, pp. 131-135. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Любимов Г.Ю., Гольдина И.А., Гришина Л.В., Гайдуль К.В. Влияние масляного экстракта Curcuma Longa L. на рост карциномы легких Льюис в эксперименте // Российский иммунологический журнал, 2014. Т. 8 (17), № 3. С. 702-704.</mixed-citation><mixed-citation xml:lang="en">Lubimov G.Yu., Goldina I.A., Grishina L.V., Gaidul K.V. The influence of Curcuma Longa L. oil extract on the Lewis lung carcinoma growth in the experiment. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2014, Vol. 8 (17), no. 3, pp. 702-704. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Маркова Е.В., Гольдина И.А., Савкин И.В. Биофлавоноиды при нейроиммунной патологии: механизмы действия и терапевтические эффекты. Красноярск: Научно-инновационный центр, 2019. 158 с.</mixed-citation><mixed-citation xml:lang="en">Markova E.V., Goldina I.A., Savkin I.V. Bioflavonoids in neuroimmune pathology: mechanisms of action, therapeutic effects. Krasnoyarsk: Research and Innovation Center, 2019. 158 p.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Нутрицевтическая композиция / Гайдуль К.В., Корнилов С.И. Патент на изобретение № 2654868. Изобретения и полезные модели. Официальный бюллетень федеральной службы по интеллектуальной собственности № 15 – 2018, 21.05.2018-27.05.2018.</mixed-citation><mixed-citation xml:lang="en">Nutriceutical composition / Gaidul K.V., Kornilov S.I. Patent No. 2654868. Inventios and utility models. Official Bullenin of the Intellectual publicity № 15 – 2018, 21.05.2018- 27.05.2018.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Сафронова И.В., Гольдина И.А., Гайдуль К.В., Козлов В.А. Содержание и фармакологические свойства биологически активных компонентов ежевики // Инновации и продовольственная безопасность, 2017. № 4 (18). С. 96-106.</mixed-citation><mixed-citation xml:lang="en">Safronova I.V., Goldina I.A., Gaidul K.V., Kozlov V.A. Content and pharmacological properties of the biologically active blackberry compounds. Innovatsii i prodovolstvennaya bezopasnost = Innovations and Food Safety, 2017, no. 4 (18), pp. 96-106. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm., 2007, Vol. 4, pp. 807-818.</mixed-citation><mixed-citation xml:lang="en">Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm., 2007, Vol. 4, pp. 807-818.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Attari F., Zahmatkesh M., Aligholi H., Mehr S.E., Sharifzadeh M., Gorji A., Mokhtari T., Khaksarian M., Hassanzadeh G. Curcumin as a double-edged sword for stem cells: dose, time and cell type-specific responses to curcumin. Daru, 2015, Vol. 23, no. 1, 33. doi: 10.1186/s40199-015-0115-8.</mixed-citation><mixed-citation xml:lang="en">Attari F., Zahmatkesh M., Aligholi H., Mehr S.E., Sharifzadeh M., Gorji A., Mokhtari T., Khaksarian M., Hassanzadeh G. Curcumin as a double-edged sword for stem cells: dose, time and cell type-specific responses to curcumin. Daru, 2015, Vol. 23, no. 1, 33. doi: 10.1186/s40199-015-0115-8.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Barilla R.M., Diskin B., Caso R.C., Lee K.B., Mohan N., Buttar C., Adam S., Sekendiz Z., Wang J., Salas R.D., Cassini M.F., Karlen J., Sundberg B., Akbar H., Levchenko D., Gakhal I., Gutierrez J., Wang W., Hundeyin M., Torres-Hernandez A., Leinwand J., Kurz E., Rossi J.A.K., Mishra A., Liria M., Sanchez G., Panta J., Loke P., Aykut B., Miller G. Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regulatory CD4+ T cells in pancreatic carcinoma. Nat. Commun., 2019, Vol. 10, no. 1, 1424. doi: 10.1038/s41467-019-09416-2.</mixed-citation><mixed-citation xml:lang="en">Barilla R.M., Diskin B., Caso R.C., Lee K.B., Mohan N., Buttar C., Adam S., Sekendiz Z., Wang J., Salas R.D., Cassini M.F., Karlen J., Sundberg B., Akbar H., Levchenko D., Gakhal I., Gutierrez J., Wang W., Hundeyin M., Torres-Hernandez A., Leinwand J., Kurz E., Rossi J.A.K., Mishra A., Liria M., Sanchez G., Panta J., Loke P., Aykut B., Miller G. Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regulatory CD4+ T cells in pancreatic carcinoma. Nat. Commun., 2019, Vol. 10, no. 1, 1424. doi: 10.1038/s41467-019-09416-2.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Berginc K., Trontelj J., Basnet N.S., Kristl A. Physiological barriers to the oral delivery of curcumin. Pharmazie, 2012, Vol. 67, no. 6, pp. 518-524.</mixed-citation><mixed-citation xml:lang="en">Berginc K., Trontelj J., Basnet N.S., Kristl A. Physiological barriers to the oral delivery of curcumin. Pharmazie, 2012, Vol. 67, no. 6, pp. 518-524.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bolat Z.B., Islek Z., Demir B.N., Yilmaz E.N., Sahin F., Ucisik M.H. Curcumin- and piperine-loaded emulsomes as combinational treatment approach enhance the anticancer activity of curcumin on HCT116 colorectal cancer model. Front. Bioeng. Biotechnol., 2020, Vol. 8, 50. doi: 10.3389/fbioe.2020.00050.</mixed-citation><mixed-citation xml:lang="en">Bolat Z.B., Islek Z., Demir B.N., Yilmaz E.N., Sahin F., Ucisik M.H. Curcumin- and piperine-loaded emulsomes as combinational treatment approach enhance the anticancer activity of curcumin on HCT116 colorectal cancer model. Front. Bioeng. Biotechnol., 2020, Vol. 8, 50. doi: 10.3389/fbioe.2020.00050.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Chang L.-C., Yu Y.-L. Dietary components as epigenetic-regulating agent against cancer. BioMedicine, 2016, Vol. 6, pp. 9-16.</mixed-citation><mixed-citation xml:lang="en">Chang L.-C., Yu Y.-L. Dietary components as epigenetic-regulating agent against cancer. BioMedicine, 2016, Vol. 6, pp. 9-16.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chen G., He L., Zhang P., Zhang J., Mei X., Wang D., Zhang Y., Ren X., Chen Z. Encapsulation of green tea polyphenol nanospheres in PVA/alginate hydrogel for promoting wound healing of diabetic rats by regulating PI3K/ AKT pathway. Mater. Sci. Eng. C. Mater. Biol., 2020, Vol. 110, 110686. doi: 10.1016/j.msec.2020.110686.</mixed-citation><mixed-citation xml:lang="en">Chen G., He L., Zhang P., Zhang J., Mei X., Wang D., Zhang Y., Ren X., Chen Z. Encapsulation of green tea polyphenol nanospheres in PVA/alginate hydrogel for promoting wound healing of diabetic rats by regulating PI3K/ AKT pathway. Mater. Sci. Eng. C. Mater. Biol., 2020, Vol. 110, 110686. doi: 10.1016/j.msec.2020.110686.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X., Wang J., Fu Z., Zhu B., Wang J., Guan S., Hua Z. Curcumin activates DNA repair pathway in bone marrow to improve carboplatin-induced myelosuppression. Sci. Rep., 2017, Vol. 7, no. 1, 17724. doi: 10.1038/s41598-017-16436-9.</mixed-citation><mixed-citation xml:lang="en">Chen X., Wang J., Fu Z., Zhu B., Wang J., Guan S., Hua Z. Curcumin activates DNA repair pathway in bone marrow to improve carboplatin-induced myelosuppression. Sci. Rep., 2017, Vol. 7, no. 1, 17724. doi: 10.1038/s41598-017-16436-9.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ding S., Jiang H., Fang J. Regulation of Immune Function by Polyphenols. J. Immunol. Res., 2018, Vol. 2018, 1264074. doi: 10.1155/2018/1264074.</mixed-citation><mixed-citation xml:lang="en">Ding S., Jiang H., Fang J. Regulation of Immune Function by Polyphenols. J. Immunol. Res., 2018, Vol. 2018, 1264074. doi: 10.1155/2018/1264074.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Dion C., Chappuis E., Ripoll C. Does larch arabinogalactan enhance immune function? A review of mechanistic and clinical trials. Nutr. Metab. (Lond)., 2016, Vol. 13, 28. doi: 10.1186/s12986-016-0086-x.</mixed-citation><mixed-citation xml:lang="en">Dion C., Chappuis E., Ripoll C. Does larch arabinogalactan enhance immune function? A review of mechanistic and clinical trials. Nutr. Metab. (Lond)., 2016, Vol. 13, 28. doi: 10.1186/s12986-016-0086-x.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Drapeau C., Benson K.F., Jensen G.S. Rapid and selective mobilization of specific stem cell types after consumption of a polyphenol-rich extract from sea buckthorn berries (Hippophae) in healthy human subjects. Clin. Interv. Aging, 2019, Vol. 14, pp. 253-263.</mixed-citation><mixed-citation xml:lang="en">Drapeau C., Benson K.F., Jensen G.S. Rapid and selective mobilization of specific stem cell types after consumption of a polyphenol-rich extract from sea buckthorn berries (Hippophae) in healthy human subjects. Clin. Interv. Aging, 2019, Vol. 14, pp. 253-263.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Farhana L., Sarkar S., Nangia-Makker P., Yu Y., Khosla P., Levi E., Azmi A., Majumdar A.P.N. Natural agents inhibit colon cancer cell proliferation and alter microbial diversity in mice. PLoS ONE, 2020, Vol. 15, no. 3, e0229823. doi: 10.1371/journal.pone.0229823.</mixed-citation><mixed-citation xml:lang="en">Farhana L., Sarkar S., Nangia-Makker P., Yu Y., Khosla P., Levi E., Azmi A., Majumdar A.P.N. Natural agents inhibit colon cancer cell proliferation and alter microbial diversity in mice. PLoS ONE, 2020, Vol. 15, no. 3, e0229823. doi: 10.1371/journal.pone.0229823.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Fu Z., Chen X., Guan S., Yan Y., Lin H., Hua Z.C. Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway. Oncotarget, 2015, Vol. 6, no. 23, pp. 19469-19482.</mixed-citation><mixed-citation xml:lang="en">Fu Z., Chen X., Guan S., Yan Y., Lin H., Hua Z.C. Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway. Oncotarget, 2015, Vol. 6, no. 23, pp. 19469-19482.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Heebkaew N., Rujanapun N., Kunhorm P., Jaroonwitchawan T., Chaicharoenaudomrung N., Promjantuek W., Noisa P. Curcumin induces neural differentiation of human pluripotent embryonal carcinoma cells through the activation of autophagy. BioMed Res. Int., 2019, 4378710. doi: 10.1155/2019/4378710.</mixed-citation><mixed-citation xml:lang="en">Heebkaew N., Rujanapun N., Kunhorm P., Jaroonwitchawan T., Chaicharoenaudomrung N., Promjantuek W., Noisa P. Curcumin induces neural differentiation of human pluripotent embryonal carcinoma cells through the activation of autophagy. BioMed Res. Int., 2019, 4378710. doi: 10.1155/2019/4378710.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Jarosz M., Olbert M., Wyszogrodzka G., Młyniec K., Librowski T. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling. Inflammopharmacology, 2017, Vol. 25, no. 1, pp. 11-24.</mixed-citation><mixed-citation xml:lang="en">Jarosz M., Olbert M., Wyszogrodzka G., Młyniec K., Librowski T. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling. Inflammopharmacology, 2017, Vol. 25, no. 1, pp. 11-24.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Jin N., Lin J., Yang C., Wu C., He J., Chen Z., Yang Q., Chen J., Zheng G., Lv L., Liang H., Chen J., Ruan Z. Enhanced penetration and anti-psoriatic efficacy of curcumin by improved smartPearls technology with the addition of glycyrrhizic acid. Int. J. Pharm., 2020, Vol. 578, 119101. doi: 10.1016/j.ijpharm.2020.119101.</mixed-citation><mixed-citation xml:lang="en">Jin N., Lin J., Yang C., Wu C., He J., Chen Z., Yang Q., Chen J., Zheng G., Lv L., Liang H., Chen J., Ruan Z. Enhanced penetration and anti-psoriatic efficacy of curcumin by improved smartPearls technology with the addition of glycyrrhizic acid. Int. J. Pharm., 2020, Vol. 578, 119101. doi: 10.1016/j.ijpharm.2020.119101.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kim M.A., Kim M.J. Isoflavone profiles and antioxidant properties in different parts of soybean sprout. J. Food Sci., 2020, Vol. 85, no. 3, pp. 689-695.</mixed-citation><mixed-citation xml:lang="en">Kim M.A., Kim M.J. Isoflavone profiles and antioxidant properties in different parts of soybean sprout. J. Food Sci., 2020, Vol. 85, no. 3, pp. 689-695.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kurbitz C., Heise D., Redmer T., Goumas F., Arlt A., Lemke J., Rimbach G., Kalthoff H., Trauzold A. Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and antiinflammatory activities in pancreatic tumor cells. Cancer Sci., 2011, Vol. 102, pp. 728-734.</mixed-citation><mixed-citation xml:lang="en">Kurbitz C., Heise D., Redmer T., Goumas F., Arlt A., Lemke J., Rimbach G., Kalthoff H., Trauzold A. Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and antiinflammatory activities in pancreatic tumor cells. Cancer Sci., 2011, Vol. 102, pp. 728-734.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Lewandowska U., Gorlach S., Owczarec K., Hrabec E., Szewczyk K. Synergistic interaction between anticancer chemotherapeutics and phenolic compounds and anticancer synergy between polyphenols. Postery Hig. Med. Dosw., 2014, Vol. 68. pp. 528-540.</mixed-citation><mixed-citation xml:lang="en">Lewandowska U., Gorlach S., Owczarec K., Hrabec E., Szewczyk K. Synergistic interaction between anticancer chemotherapeutics and phenolic compounds and anticancer synergy between polyphenols. Postery Hig. Med. Dosw., 2014, Vol. 68. pp. 528-540.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Manayi A., Nabavi S.M., Setzer W.N., Jafari S. Piperine as a potential anti-cancer agent: a review on preclinical studies. Curr. Med. Chem., 2018, Vol. 25, no. 37, pp. 4918-4928.</mixed-citation><mixed-citation xml:lang="en">Manayi A., Nabavi S.M., Setzer W.N., Jafari S. Piperine as a potential anti-cancer agent: a review on preclinical studies. Curr. Med. Chem., 2018, Vol. 25, no. 37, pp. 4918-4928.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Markova E.V., Goldina I.A., Goldin B.G., Knyazheva M.A., Savkin I.V. Turmeric extract in correction of nervous and immune systems functional activity parameters in experimental alcoholism. Мed. Acad. J., 2019, Vol. 19, № S, pp. 215-217.</mixed-citation><mixed-citation xml:lang="en">Markova E.V., Goldina I.A., Goldin B.G., Knyazheva M.A., Savkin I.V. Turmeric extract in correction of nervous and immune systems functional activity parameters in experimental alcoholism. Мed. Acad. J., 2019, Vol. 19, № S, pp. 215-217.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Namiki K., Wongsirisin P., Yokoyama S., Sato M., Rawangkan A., Sakai R., Iida K., Suganuma M. (-)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells. Sci. Rep., 2020, Vol. 10, no. 1, 2444. doi: 10.1038/s41598-020-59281-z.</mixed-citation><mixed-citation xml:lang="en">Namiki K., Wongsirisin P., Yokoyama S., Sato M., Rawangkan A., Sakai R., Iida K., Suganuma M. (-)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells. Sci. Rep., 2020, Vol. 10, no. 1, 2444. doi: 10.1038/s41598-020-59281-z.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Niedzwiecki A., Roomi M.W., Kalinovsky T., Rath M. Anticancer efficacy of polyphenols and their combinations. Nutrients, 2016, Vol. 8, no. 9, 552. doi: 10.3390/nu8090552.</mixed-citation><mixed-citation xml:lang="en">Niedzwiecki A., Roomi M.W., Kalinovsky T., Rath M. Anticancer efficacy of polyphenols and their combinations. Nutrients, 2016, Vol. 8, no. 9, 552. doi: 10.3390/nu8090552.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Niraula S., Amir E., Vera-Badillo F., Seruga B., Ocana A., Tannock I.F. Risk of incremental toxicities and associated costs of new anticancer drugs: a meta-analysis. J. Clin. Oncol., 2014, Vol. 32, pp. 3634-3642.</mixed-citation><mixed-citation xml:lang="en">Niraula S., Amir E., Vera-Badillo F., Seruga B., Ocana A., Tannock I.F. Risk of incremental toxicities and associated costs of new anticancer drugs: a meta-analysis. J. Clin. Oncol., 2014, Vol. 32, pp. 3634-3642.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Pan P., Huang Y.W., Oshima K., Yearsley M., Zhang J., Arnold M., Yu J., Wang L.S. The immunomodulatory potential of natural compounds in tumor-bearing mice and humans. Crit. Rev. Food. Sci. Nutr., 2019, Vol. 59, no. 6, pp. 1-16.</mixed-citation><mixed-citation xml:lang="en">Pan P., Huang Y.W., Oshima K., Yearsley M., Zhang J., Arnold M., Yu J., Wang L.S. The immunomodulatory potential of natural compounds in tumor-bearing mice and humans. Crit. Rev. Food. Sci. Nutr., 2019, Vol. 59, no. 6, pp. 1-16.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Plitas G., Rudensky A.Y. Regulatory T cells: differentiation and function. Cancer Immunol. Res., 2016, Vol. 4, pp. 721-725.</mixed-citation><mixed-citation xml:lang="en">Plitas G., Rudensky A.Y. Regulatory T cells: differentiation and function. Cancer Immunol. Res., 2016, Vol. 4, pp. 721-725.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Ruffell B., Chang-Strachan D., Chan V., Rosenbusch A., Ho C.M., Pryer N., Daniel D., Hwang E.S., Rugo H.S., Coussens L.M. Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell., 2014, Vol. 26, no. 5, pp. 623-637.</mixed-citation><mixed-citation xml:lang="en">Ruffell B., Chang-Strachan D., Chan V., Rosenbusch A., Ho C.M., Pryer N., Daniel D., Hwang E.S., Rugo H.S., Coussens L.M. Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell., 2014, Vol. 26, no. 5, pp. 623-637.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma A., Shahzad B., Rehman A., Bhardwaj R., Landi M., Zheng B. Response of phenylpropanoid pathway and the role of polyphenols in plants under abiotic stress. Molecules, 2019, Vol. 24, no. 13, 2452. doi: 10.3390/molecules24132452.</mixed-citation><mixed-citation xml:lang="en">Sharma A., Shahzad B., Rehman A., Bhardwaj R., Landi M., Zheng B. Response of phenylpropanoid pathway and the role of polyphenols in plants under abiotic stress. Molecules, 2019, Vol. 24, no. 13, 2452. doi: 10.3390/molecules24132452.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Snopek L., Mlcek J., Sochorova L., Baron M., Hlavacova I., Jurikova T., Kizek R., Sedlackova E., Sochor J. Contribution of red wine consumption to human health protection. Molecules, 2018, Vol. 23, no. 7, 1684. doi: 10.3390/molecules23071684.</mixed-citation><mixed-citation xml:lang="en">Snopek L., Mlcek J., Sochorova L., Baron M., Hlavacova I., Jurikova T., Kizek R., Sedlackova E., Sochor J. Contribution of red wine consumption to human health protection. Molecules, 2018, Vol. 23, no. 7, 1684. doi: 10.3390/molecules23071684.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Szade K., Gulati G.S., Chan C.K.F., Kao K.S., Miyanishi M., Marjon K.D., Sinha R., George B.M., Chen J.Y., Weissman I.L. Where hematopoietic stem cells live: the Bone marrow niche. Antioxid. Redox Signal., 2018, Vol. 29(2), pp. 191-204.</mixed-citation><mixed-citation xml:lang="en">Szade K., Gulati G.S., Chan C.K.F., Kao K.S., Miyanishi M., Marjon K.D., Sinha R., George B.M., Chen J.Y., Weissman I.L. Where hematopoietic stem cells live: the Bone marrow niche. Antioxid. Redox Signal., 2018, Vol. 29(2), pp. 191-204.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Wu P., Wu D., Zhao L., Huang L., Chen G., Shen G., Huang J., Chai Y. Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis. Oncotarget, 2016, Vol. 7, pp. 40451-40460.</mixed-citation><mixed-citation xml:lang="en">Wu P., Wu D., Zhao L., Huang L., Chen G., Shen G., Huang J., Chai Y. Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis. Oncotarget, 2016, Vol. 7, pp. 40451-40460.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Yang X., Xue Z., Fang Y., Liu X., Yang Y., Shi G., Feng S., Zhao L. Structure-immunomodulatory activity relationships of Hedysarum polysaccharides extracted by a method involving a complex enzyme combined with ultrasonication. J. Food Funct., 2019, Vol. 10, no. 2, pp. 1146-1158.</mixed-citation><mixed-citation xml:lang="en">Yang X., Xue Z., Fang Y., Liu X., Yang Y., Shi G., Feng S., Zhao L. Structure-immunomodulatory activity relationships of Hedysarum polysaccharides extracted by a method involving a complex enzyme combined with ultrasonication. J. Food Funct., 2019, Vol. 10, no. 2, pp. 1146-1158.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao L.G., Chen T.Q., Feng D.M., Xiao T.G., Dang Z.L., Feng S.L., Xia Y.Y. Structural characterization and antioxidant activity of a heteropolysaccharide isolated from Hedysarum polybotrys. J. Asian Nat. Prod. Res., 2014, Vol. 16(6), pp. 677-684.</mixed-citation><mixed-citation xml:lang="en">Zhao L.G., Chen T.Q., Feng D.M., Xiao T.G., Dang Z.L., Feng S.L., Xia Y.Y. Structural characterization and antioxidant activity of a heteropolysaccharide isolated from Hedysarum polybotrys. J. Asian Nat. Prod. Res., 2014, Vol. 16(6), pp. 677-684.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y., Shao Q., Zhu H., Xu H., Long W., Yu B., Zhou L., Xu H., Wu Y., Su Z. Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability. Cancer Sci., 2018, Vol. 109, no. 9, pp. 2677-2686.</mixed-citation><mixed-citation xml:lang="en">Zhao Y., Shao Q., Zhu H., Xu H., Long W., Yu B., Zhou L., Xu H., Wu Y., Su Z. Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability. Cancer Sci., 2018, Vol. 109, no. 9, pp. 2677-2686.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Zou J.Y., Su C.H., Luo H.H., Lei Y.Y., Zeng B., Zhu H.S., Chen Z.G. Curcumin converts Foxp3+ regulatory T cells to T helper 1 cells in patients with lung cancer. J. Cell Biochem., 2018, Vol. 119, no. 2, pp. 1420-1428.</mixed-citation><mixed-citation xml:lang="en">Zou J.Y., Su C.H., Luo H.H., Lei Y.Y., Zeng B., Zhu H.S., Chen Z.G. Curcumin converts Foxp3+ regulatory T cells to T helper 1 cells in patients with lung cancer. J. Cell Biochem., 2018, Vol. 119, no. 2, pp. 1420-1428.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
